The Presence of ANCA in IgA Crescentic Nephropathy Does Not Lead to Worse Prognosis with Intensive Rescue Treatment

Background: Immunoglobulin A nephropathy (IgAN) is the most common glomerulonephritis worldwide. The concomitant presence of both crescentic proliferation and anti-neutrophil cytoplasmic autoantibodies (ANCA) in this pathology represents a rare coincidence. However, it is not clear to what extent the presence of ANCA (IgA or IgG) in these patients could have any clinical significance. The aim of the current work is to describe the presence of ANCA (IgA or IgG) in patients with IgAN and crescentic proliferation and its possible clinical implications. Methods: We retrospectively recruited all patients in our center with a histological diagnosis of IgAN with crescentic proliferation between January 2013 and December 2020. The main demographic and clinicopathologic data, fundamental histological characteristics, as well as the treatments implemented and main kidney outcomes, were collected and analyzed at a 6 and 12-month follow-up. Results: Between January 2013 and December 2020, a total of 17 adults were diagnosed with concomitant crescentic proliferation through a kidney biopsy of IgAN. Five (29.4%) patients showed ANCA, three (60%) showed IgA-ANCA and two (40%) showed IgG-ANCA. All ANCA-positive patients had some degree of crescentic proliferation. At diagnosis, the mean age of patients was 48 years old (range: 27–75). Nine of them were women (52%) and the most common clinical presentation was hypertension (71%). At the time of biopsy, the mean serum creatinine and proteinuria were 2.2 mg/dL (DS 1.42) and 3.5 g/mgCr (DS 1.22), respectively, with no statistical differences between ANCA-positive and -negative patients. Histological analyses showed that 11 out of the 12 (91%) ANCA-negative IgAN patients displayed less than 25% cellular crescents, whereas 100% of ANCA-positive IgAN patients displayed more than 25% cellular crescents (p = 0.04). Notably, five (30%) patients displayed fibrinoid necrosis, with four of them (80%) being IgAN-ANCA-positive (p = 0.01). Only one ANCA-negative patient needed renal replacement therapy (RRT) upon admission (5%). The mean serum creatinine and proteinuria were 1.94 mg/dL (DS 1.71) and 1.45 g/gCr (DS 1.78), respectively, within 6 months of immunosuppressive therapy. At 12-month follow-up, the mean creatinine was 1.57 mg/dL (DS 1). Four (23.5%) patients needed RRT at the end of the follow-up and four (23.5%) patients died. Conclusions: Probably due to the limited number of IgAN-ANCA-positive and IgAN-ANCA-negative patients, no significant differences were found between the clinical and laboratory characteristics. IgAN-ANCA-negative patients seemed to display less extracapillary proliferation than IgAN-ANCA-positive patients, who tended to show significantly higher fibrinoid necrosis. There were no differences regarding renal prognosis and patient survival after aggressive immunosuppressive therapy within 6 and 12 months when comparing the two samples.

[1]  Hong Zhang,et al.  O-glycoforms of polymeric IgA1 in the plasma of patients with IgA nephropathy are associated with pathological phenotypes. , 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  Gabriel Ștefan,et al.  IgA nephropathy with serum ANCA positivity: case series and literature review , 2021, Rheumatology International.

[3]  Jianghua Chen,et al.  The Clinicopathologic Characteristics and Complement Activation of Antineutrophil Cytoplasmic Antibody-associated Vasculitides With Glomerular IgA Deposition , 2019, Applied immunohistochemistry & molecular morphology : AIMM.

[4]  Su-xia Wang,et al.  A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy. , 2017, Journal of the American Society of Nephrology : JASN.

[5]  Min Chen,et al.  Clinical features of IgA nephropathy with serum ANCA positivity: a retrospective case–control study , 2015, Clinical kidney journal.

[6]  Birgitte Bang Pedersen,et al.  Use of eculizumab in crescentic IgA nephropathy: proof of principle and conundrum? , 2015, Clinical kidney journal.

[7]  K. Ivens,et al.  Is presence of ANCA in crescentic IgA nephropathy a coincidence or novel clinical entity? A case series. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  Fernand,et al.  The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. , 2009, Kidney international.

[9]  J. Bonet,et al.  [IgA nephropathy with crescentic glomerulonephritis and ANCA positive]. , 2005, Nefrología.

[10]  T. Dougan,et al.  Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. , 2004, Kidney international.

[11]  S. Adler,et al.  ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  S. Rosen,et al.  IgG antineutrophil cytoplasmic antibodies in IgA nephropathy: a clinical variant? , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  R. Coppo,et al.  Properties of circulating IgA molecules in Henoch-Schönlein purpura nephritis with focus on neutrophil cytoplasmic antigen IgA binding (IgA-ANCA): new insight into a debated issue. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schönlein purpura in adults and in children. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  E. Ritz,et al.  Rapidly progressive IgA nephropathy with anti-myeloperoxidase antibodies benefits from immunosuppression. , 1997, Clinical nephrology.

[15]  Masaki Kobayashi,et al.  Natural history and risk factors for immunoglobulin a nephropathy in Japan , 1997 .

[16]  G. D'Amico,et al.  Lack of IgA antineutrophil cytoplasmic antibodies in Henoch-Schönlein purpura and IgA nephropathy. , 1994, Clinical immunology and immunopathology.

[17]  D. O'donoghue,et al.  Mesangial cell autoantigens in immunoglobulin A nephropathy and Henoch-Schönlein purpura. , 1991, The Journal of clinical investigation.

[18]  G. D'Amico,et al.  The commonest glomerulonephritis in the world: IgA nephropathy. , 1987, The Quarterly journal of medicine.